INIFY — INIFY Laboratories AB Balance Sheet
0.000.00%
Last trade - 00:00- NOK273.68m
- NOK250.15m
- SEK13.13m
Annual balance sheet for INIFY Laboratories AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | PRESS |
| Standards: | SAS | SAS | — |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 129 | 70.9 | 22.7 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 3.11 | 3.69 | 6.09 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Net Property, Plant And Equipment | 9.34 | 9.14 | 8.14 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Total Other Assets | |||
| Total Assets | 152 | 93 | 42.9 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 13.8 | 7.95 | 9.5 |
| Common Stock | |||
| Other Equity | |||
| Total Equity | 138 | 85 | 33.4 |
| Total Liabilities & Shareholders' Equity | 152 | 93 | 42.9 |
| Total Common Shares Outstanding |